BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Feb. 3, 1992
View Archived Issues
ANALYST LOWERS AMGEN RATING
Read More
GENSIA TO SPLIT STOCK 3 for 2
Read More
BELGIUM APPROVES BTGC GROWTH HORMONE
Read More
GENELABS DEAL FOR ANTI-CANCER DRUG
Read More
APPOINTMENTS AND ADVANCEMENTS
Read More
SOMATIX LICENSES MYOBLAST GENE THERAPY
Read More
FEDERAL BIOTECH PRIORITIES FOR 21st CENTURY
Read More
JUDGE REFUSES TO SET ASIDE XOMA RULING
Read More
$687 MILLION IN OFFERINGS FOR MONTH
Read More
FDA PANEL TURNS DOWN U.S. BIO'S ETHYOL
Read More